T2D: Clinical Trials

2 trials for T2D, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Unknown 2
Phase 21Unknown 1

Follow T2D: new trials by email Literature Review of T2D trials Research Report on T2D

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study on the Efficacy and Safety of Chiglitazar Sodium in PCOS With T2DM
pioglitazone group: lifestyle intervention+ metformin+ orlistat (obese patients)+ pioglitazone, the Chiglitazar group: lifestyle intervention+ metformin+ orlistat (obese patients)+ Chiglitazar - PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries, T2D
Phase 1UnknownAffiliated Hospital of Nantong University1422022-10-012023-08-01
BM-MNC and UCMSC for Type 2 Diabetes Mellitus Patients
Bone-marrow aspiration, Intra-pancreatic Catheterisation of BM-MNC, Intravenous Infusion of UC-MSC - T2D
Phase 1 / Phase 2UnknownUniversitas Indonesia152016-03-142020-08-06

Narrower conditions

Diabetes Mellitus, Type 2 (1)  ·  Polycystic Ovary Syndrome (1)

Broader conditions

Endocrine System Diseases (2)  ·  Adnexal Diseases (1)  ·  Cysts (1)  ·  Diabetes Mellitus (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Female (1)  ·  Glucose Metabolism Disorders (1)  ·  Gonadal Disorders (1)  ·  Metabolic Diseases (1)  ·  Neoplasms (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Ovarian Cysts (1)  ·  Ovarian Diseases (1)

Sponsors

Affiliated Hospital of Nantong University (1)  ·  Universitas Indonesia (1)

Countries

China (1)  ·  Indonesia (1)

Results publications

PMID 26794657, PMID 31214172